Yuhan Balance Sheet Health

Financial Health criteria checks 5/6

Yuhan has a total shareholder equity of ₩2,174.6B and total debt of ₩263.5B, which brings its debt-to-equity ratio to 12.1%. Its total assets and total liabilities are ₩2,925.7B and ₩751.2B respectively. Yuhan's EBIT is ₩72.6B making its interest coverage ratio 14.3. It has cash and short-term investments of ₩249.0B.

Key information

12.1%

Debt to equity ratio

₩263.48b

Debt

Interest coverage ratio	14.3x
Cash	₩249.00b
Equity	₩2.17t
Total liabilities	₩751.18b
Total assets	₩2.93t

Recent financial health updates

Is Yuhan (KRX:000100) Using Too Much Debt?

Oct 08

Here's Why Yuhan (KRX:000100) Can Manage Its Debt Responsibly

May 13

Recent updates

Yuhan Corporation (KRX:000100) May Have Run Too Fast Too Soon With Recent 25% Price Plummet

Nov 14

Is Yuhan (KRX:000100) Using Too Much Debt?

Oct 08

Estimating The Intrinsic Value Of Yuhan Corporation (KRX:000100)

Sep 16

Subdued Growth No Barrier To Yuhan Corporation (KRX:000100) With Shares Advancing 41%

Aug 28

Yuhan Corporation's (KRX:000100) Price In Tune With Earnings

Jul 01

Yuhan Corporation (KRX:000100) Shares Could Be 37% Below Their Intrinsic Value Estimate

Jun 13

Yuhan's (KRX:000100) Earnings Are Weaker Than They Seem

May 26

Here's Why Yuhan (KRX:000100) Can Manage Its Debt Responsibly

May 13

Yuhan Corporation's (KRX:000100) P/E Is Still On The Mark Following 26% Share Price Bounce

Mar 11

Financial Position Analysis

Short Term Liabilities: A000100's short term assets (₩1,309.1B) exceed its short term liabilities (₩570.5B).

Long Term Liabilities: A000100's short term assets (₩1,309.1B) exceed its long term liabilities (₩180.7B).

Debt to Equity History and Analysis

Debt Level: A000100's net debt to equity ratio (0.7%) is considered satisfactory.

Reducing Debt: A000100's debt to equity ratio has increased from 5.8% to 12.1% over the past 5 years.

Debt Coverage: A000100's debt is well covered by operating cash flow (22.7%).

Interest Coverage: A000100's interest payments on its debt are well covered by EBIT (14.3x coverage).

Yuhan Balance Sheet Health

Financial Health criteria checks 5/6

Key information

Recent financial health updates

Is Yuhan (KRX:000100) Using Too Much Debt?

Here's Why Yuhan (KRX:000100) Can Manage Its Debt Responsibly

Recent updates

Now 21% overvalued

Price target increased by 8.2% to ₩132,214

Dividend of ₩429 announced

Yuhan Corporation (KRX:000100) May Have Run Too Fast Too Soon With Recent 25% Price Plummet

Is Yuhan (KRX:000100) Using Too Much Debt?

Price target increased by 8.1% to ₩110,188

Price target increased by 7.9% to ₩108,412

Investor sentiment improves as stock rises 17%

Estimating The Intrinsic Value Of Yuhan Corporation (KRX:000100)

Investor sentiment improves as stock rises 44%

Subdued Growth No Barrier To Yuhan Corporation (KRX:000100) With Shares Advancing 41%

Price target increased by 7.1% to ₩99,222

Investor sentiment deteriorates as stock falls 15%

Now 20% undervalued

Investor sentiment improves as stock rises 15%

Yuhan Corporation's (KRX:000100) Price In Tune With Earnings

Yuhan Corporation (KRX:000100) Shares Could Be 37% Below Their Intrinsic Value Estimate

Investor sentiment improves as stock rises 19%

Yuhan's (KRX:000100) Earnings Are Weaker Than They Seem

Consensus revenue estimates increase by 28%

Here's Why Yuhan (KRX:000100) Can Manage Its Debt Responsibly

Now 22% overvalued after recent price rise

Full year 2023 earnings released: EPS: ₩1,815 (vs ₩1,267 in FY 2022)

Yuhan Corporation's (KRX:000100) P/E Is Still On The Mark Following 26% Share Price Bounce

Investor sentiment improves as stock rises 18%

Insufficient new directors

Now 21% undervalued

Upcoming dividend of ₩381 per share at 0.6% yield

Consensus EPS estimates increase by 37%, revenue downgraded

Investor sentiment deteriorates as stock falls 23%

Now 24% undervalued

Price target increased by 7.8% to ₩80,222

First quarter 2023 earnings released: EPS: ₩311 (vs ₩222 in 1Q 2022)

Full year 2022 earnings: EPS exceeds analyst expectations while revenues lag behind

Now 21% undervalued after recent price drop

Upcoming dividend of ₩381 per share

Consensus EPS estimates fall by 11%

Now 20% undervalued

Full year 2021 earnings: EPS and revenues miss analyst expectations

Yuhan Corporation (KOSE:A000100) announces an Equity Buyback for KRW 20,000 million worth of its shares.

Upcoming dividend of ₩381 per share

Third quarter 2021 earnings released: EPS ₩470 (vs ₩464 in 3Q 2020)

First quarter 2021 earnings released: EPS ₩315 (vs ₩1,768 in 1Q 2020)

Consensus forecasts updated

Full year 2020 earnings released: EPS ₩2,943 (vs ₩610 in FY 2019)

New 90-day low: ₩60,700

Yuhan Corporation, Annual General Meeting, Mar 19, 2021

New 90-day high: ₩75,100

New 90-day high: ₩75,100

New 90-day high: ₩72,300

Price target raised to ₩72,704

Price target raised to ₩67,579

Yuhan Corporation and Sorrento Therapeutics, Inc. Announces Completion of Phase 1 Clinical Study of Anti-PD-L1 Antibody IMC-001

New 90-day high: ₩72,000

Price target raised to ₩63,148

Financial Position Analysis

Debt to Equity History and Analysis

Balance Sheet

Discover healthy companies